Literature DB >> 9240942

Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis.

A T Cohen1, M B Wagner, M S Mohamed.   

Abstract

BACKGROUND: Patients undergoing major abdominal surgery are at risk of both bleeding and thrombotic complications and usually receive heparin thromboprophylaxis. PATIENTS AND METHODS: Risk factors for perioperative bleeding were examined in 3,809 patients in a double-blind, randomized trial investigating heparin thromboprophylaxis. The risk factors were modeled by logistic regression, and a risk score was calculated using the significant factors in the model.
RESULTS: Bleeding was associated with the following factors in the model, given as adjusted odds ratios (ORa [95% confidence interval]): male sex (ORa 1.68 [1.21 to 2.34] P = 0.003), malignancy (ORa 1.69 [1.21 to 2.34] P = 0.008), gynecological surgery (ORa 1.62 [1.12 to 2.35] P = 0.011), and complex surgery (ORa 2.7 [2.02 to 3.62] P < 0.001). The risk of excessive bleeding for 0, 1, 2, and 3 risk factors was 2%, 6%, 11%, and 21%, respectively.
CONCLUSIONS: The recognition of patients with these risk factors associated with perioperative bleeding should result in increased vigilance and may lead to modification of surgical and medical therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240942     DOI: 10.1016/S0002-9610(97)00050-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  16 in total

1.  Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial.

Authors:  R S McLeod; W H Geerts; K W Sniderman; C Greenwood; R C Gregoire; B M Taylor; R E Silverman; K G Atkinson; M Burnstein; J C Marshall; C J Burul; D R Anderson; T Ross; S R Wilson; P Barton
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

2.  General surgery in patients with a bleeding diathesis: how we do it.

Authors:  Kamal R Aryal; D Wiseman; Ajith K Siriwardena; Paula H B Bolton-Maggs; Charles R M Hay; James Hill
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

3.  Incidence of Venous Thromboembolism Following Laparoscopic Surgery for Gastrointestinal Cancer: A Single-Center, Prospective Cohort Study.

Authors:  Yasue Kimura; Eiji Oki; Koji Ando; Hiroshi Saeki; Tetsuya Kusumoto; Yoshihiko Maehara
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

4.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

5.  Defining incidence and risk factors of venous thromboemolism after hepatectomy.

Authors:  Aslam Ejaz; Gaya Spolverato; Yuhree Kim; Donald L Lucas; Brandyn Lau; Matthew Weiss; Fabian M Johnston; Marin Kheng; Marian Kheng; Kenzo Hirose; Christopher L Wolfgang; Elliott Haut; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2013-12-13       Impact factor: 3.452

6.  Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial.

Authors:  Nathan P Clark; James D Douketis; Vic Hasselblad; Sam Schulman; Andrei L Kindzelski; Thomas L Ortel
Journal:  Am Heart J       Date:  2017-09-21       Impact factor: 4.749

Review 7.  Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.

Authors:  Lara A Kahale; Maram B Hakoum; Ibrahim G Tsolakian; Charbel F Matar; Maddalena Barba; Victor E D Yosuico; Irene Terrenato; Francesca Sperati; Holger Schünemann; Elie A Akl
Journal:  Cochrane Database Syst Rev       Date:  2017-12-29

Review 8.  Disease risk score as a confounder summary method: systematic review and recommendations.

Authors:  Mina Tadrous; Joshua J Gagne; Til Stürmer; Suzanne M Cadarette
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-11-21       Impact factor: 2.890

Review 9.  Anticoagulation for people with cancer and central venous catheters.

Authors:  Lara A Kahale; Ibrahim G Tsolakian; Maram B Hakoum; Charbel F Matar; Maddalena Barba; Victor Ed Yosuico; Irene Terrenato; Francesca Sperati; Holger Schünemann; Elie A Akl
Journal:  Cochrane Database Syst Rev       Date:  2018-06-01

Review 10.  Parenteral anticoagulation in ambulatory patients with cancer.

Authors:  Elie A Akl; Lara A Kahale; Maram B Hakoum; Charbel F Matar; Francesca Sperati; Maddalena Barba; Victor E D Yosuico; Irene Terrenato; Anneliese Synnot; Holger Schünemann
Journal:  Cochrane Database Syst Rev       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.